FDA Approves Basal-IQ Predictive Low Suspend for the t:slim X2 Pump from Tandem


Tandem announces FDA approval of the Basal-IQ™ technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events for the t:slim X2™ Insulin Pump.READ MORE

Breaking News From #2018ADA


The most important and groundbreaking news coming out of the 78th Scientific Sessions, updated regularly over the course of the conferenceREAD MORE